Company research
Ardent Health, Inc.
CIK 1756655Updated Sep 25, 2026
SecurityARDT · NYSE · equity
Name history
Ardent Health Partners, Inc. · through May 23, 2025Ardent Health Partners, LLC · through Jul 16, 2024
ARDT price & chart
Loading TradingView…
NYSE:ARDT on TradingView ↗About the company
Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. The Company delivers care through its subsidiaries, which include 30 acute care hospitals and more than 280 sites of care with over 1,800 employed and affiliated providers across six states. Anchored by a shared operating model and a commitment to
In the news
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm ↗
ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT ↗
MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law ↗
Recent filings
Other Events
Items 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
4 filing
Show 5 more recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
ARS filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 5,290,208,000Source | 4,956,100,000Source | 4,731,558,000Source |
| Property, Plant and Equipment, NetUSD | — | 861,899,000Source | 811,089,000Source |
| GoodwillUSD | 879,451,000Source | 852,084,000Source | 844,704,000Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 709,601,000Source | 556,785,000Source | 437,577,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 686,102,000Source | 743,031,000Source | 775,452,000Source |
| Inventory, NetUSD | 118,593,000Source | 115,093,000Source | 105,485,000Source |
| Assets, CurrentUSD | 2,058,824,000Source | 1,832,751,000Source | 1,618,085,000Source |
| Other Assets, NoncurrentUSD | 111,691,000Source | 142,969,000Source | 147,106,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 3,605,244,000Source | 3,433,743,000Source | 3,649,242,000Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,429,000Source | 1,428,000Source | 0Source |
| Additional Paid in CapitalUSD | 788,472,000Source | 754,415,000Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | 501,607,000Source | 365,796,000Source | 155,453,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -3,610,000Source | 9,737,000Source | 18,561,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,287,898,000Source | 1,131,376,000Source | 670,896,000Source |
| Liabilities and EquityUSD | 5,290,208,000Source | 4,956,100,000Source | 4,731,558,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 1,046,544,000Source | 945,424,000Source | 994,104,000Source |
| Operating Lease, Liability, CurrentUSD | 53,499,000Source | 46,381,000Source | 42,428,000Source |
| Accounts Payable, CurrentUSD | 457,936,000Source | 401,249,000Source | 474,543,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,165,232,000Source | 1,140,756,000Source | — |
| Other Liabilities, NoncurrentUSD | 76,636,000Source | 34,697,000Source | 76,002,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 398,316,000Source | 389,823,000Source | 404,118,000Source |
| Additional Financial Items | |||
| Deferred Tax Liabilities, NetUSD | 26,558,000Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 23,444,000Source | 9,234,000Source | 18,605,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 1,075,782,000Source | 1,085,818,000Source | 1,168,253,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | -1,250,000Source | 1,158,000Source | 7,302,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 230,135,000Source | 299,708,000Source | 128,977,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 155,703,000Source | 146,288,000Source | 140,842,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -59,155,000Source | -40,001,000Source | 181,099,000Source |
| Increase (Decrease) in InventoriesUSD | 3,148,000Source | 9,407,000Source | -1,665,000Source |
| Deferred Income Tax Expense (Benefit)USD | 43,594,000Source | 23,281,000Source | 4,754,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 470,510,000Source | 315,026,000Source | 221,698,000Source |
| Cash flows from investing activities: | |||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 2,504,000Source | 35,542,000Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -214,229,000Source | -220,460,000Source | -137,983,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -179,000Source | 1,707,000Source | 575,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -103,465,000Source | 24,642,000Source | -102,262,000Source |
| Dividends paid | — | — | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -5,231,000Source | 5,243,000Source | -7,209,000Source |
| Repayments of Long-term DebtUSD | 7,988,000Source | 108,371,000Source | 13,645,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 152,816,000Source | 119,208,000Source | -18,547,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 709,601,000Source | 556,785,000Source | 437,577,000Source |
| Supplemental disclosure of cash flow information: | |||
| Income Taxes Paid, NetUSD | 36,510,000Source | 41,603,000Source | 19,433,000Source |
| Additional Financial Items | |||
| Amortization of Debt Issuance Costs and DiscountsUSD | 4,379,000Source | 5,468,000Source | 4,988,000Source |
| Amortization of Intangible AssetsUSD | 800,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -515,000Source | -2,158,000Source | 0Source |
| General and Administrative ExpenseUSD | 140,800,000Source | 132,400,000Source | 114,600,000Source |
| GoodwillUSD | 879,451,000Source | 852,084,000Source | 844,704,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — |
| Income Tax Expense (Benefit)USD | 56,223,000Source | 63,352,000Source | 22,637,000Source |
| Net Income (Loss) Attributable to ParentUSD | 135,811,000Source | 210,343,000Source | 53,904,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 94,324,000Source | 89,365,000Source | 75,073,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 135,811,000Source | 210,343,000Source | 53,904,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 3,600,000Source | 6,619,000Source |
| Stock or Unit Option Plan ExpenseUSD | 39,293,000Source | 17,978,000Source | 904,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total RevenueUSD | 6,324,339,000Source | 5,966,072,000Source | 5,409,483,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 286,358,000Source | 363,060,000Source | 151,614,000Source |
| Income Tax Expense (Benefit)USD | 56,223,000Source | 63,352,000Source | 22,637,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 94,324,000Source | 89,365,000Source | 75,073,000Source |
| Net Income (Loss) Attributable to ParentUSD | 135,811,000Source | 210,343,000Source | 53,904,000Source |
| Earnings Per Share, BasicUSD per share | 0.96Source | 1.59Source | 0.43Source |
| Earnings Per Share, DilutedUSD per share | 0.96Source | 1.58Source | 0.43Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 140,760,736Source | 132,439,695Source | 126,115,301Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 141,450,309Source | 132,744,577Source | 126,115,301Source |
| Additional Financial Items | |||
| Amortization of Intangible AssetsUSD | 800,000Source | — | — |
| Costs and ExpensesUSD | 6,037,981,000Source | 5,603,012,000Source | 5,257,869,000Source |
| Current Income Tax Expense (Benefit)USD | 12,629,000Source | 40,071,000Source | 17,883,000Source |
| General and Administrative ExpenseUSD | 140,800,000Source | 132,400,000Source | 114,600,000Source |
| InterestExpenseOperatingUSD | 55,202,000Source | — | — |
| Labor and Related ExpenseUSD | 2,657,700,000Source | 2,534,756,000Source | 2,384,062,000Source |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling InterestUSD | -96,732,000Source | -95,509,000Source | -78,567,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 135,811,000Source | 210,343,000Source | 53,904,000Source |
| Other Cost and Expense, OperatingUSD | 647,308,000Source | 496,219,000Source | 451,737,000Source |
| Other IncomeUSD | 119,377,000Source | 106,581,000Source | 93,061,000Source |
Filing attachments
ardt-090426x8xkxex991.htm · 8-K · 2026-09-04
EX-99.1 2 ardt-090426x8xkxex991.htm EX-99.1 ARDT - 09.04.26 - 8-K - EX99.1 1 EXHIBIT 99.1 The following sections of “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”) of Ardent Health, Inc., as filed with the Securities and Exchange Commission on March 16, 2026, are hereby revised as follows below. All other information contained in the 2025 Form 10…
Read attachment ↗ardt-q226x8xkxex991.htm · 8-K · 2026-08-04
EX-99.1 2 ardt-q226x8xkxex991.htm EX-99.1 ARDT - Q2 26 - 8-K - EX99.1 1 Exhibit 99.1 Ardent Health Reports Second Quarter 2026 Results Brentwood, Tenn. (August 4, 2026) - Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended June 30, 2026. Second Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year…
Read attachment ↗d854796dex991.htm · 8-K · 2026-06-02
EX-99.1 3 d854796dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Ardent Health Appoints Dave Caspers as CEO Mr. Caspers brings decades of operational expertise and a deep understanding of Ardent Health’s mission to enhance healthcare access and service Transition positions Ardent Health for its next phase of growth centered on operational efficiency and sharpening execution, building on the strong foundation established under Marty Bonick’s leadership Reaffirms full-year 2026 Adjusted EBITDA …
Read attachment ↗ardt-q126x8xkxex991.htm · 8-K · 2026-05-05
EX-99.1 2 ardt-q126x8xkxex991.htm EX-99.1 ARDT - Q1 26 - 8-K - EX99.1 1 Exhibit 99.1 Ardent Health Reports First Quarter 2026 Results Brentwood, Tenn. (May 5, 2026) - Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2026. First Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year per…
Read attachment ↗